Trial Profile
Open Label Single Arm Phase II Immunotherapy Trial in Patients With Cervical Cancer
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 04 Nov 2021
Price :
$35
*
At a glance
- Drugs V3-Cervix (Primary)
- Indications Cervical cancer
- Focus Therapeutic Use
- Sponsors Immunitor
- 15 Jun 2018 New trial record